| WeekNo; |
TC (mmol/l) |
TG (mmol/l) |
| GI(n=12) |
GII ٭(n=12) |
GIII ٭(n=12) |
GIV ٭٭(n=12) |
GI(n=12) |
GII ٭(n=12) |
GIII ٭(n=12) |
GIV ٭٭(n=12) |
| Day 0 |
4.23 ± 1.3 |
4.57 ± 0.19 |
4.75 ± 0.61 |
4.89 ± 0.3 |
0.83 ± 0.23 |
0.86 ± 0.09 |
0.82 ± 0.2 |
0.92 ± 0.16 |
| Week 2 |
4.88 ± 0.08 |
5.95 ± 0.53 |
5.79 ± 0.52 |
8.65 ± 0.21 |
0.78 ± 0.26 |
1.89 ± 0.27 |
1.84 ± 031 |
4.35 ± 0.32 |
| Week 4 |
4.27 ± 0.38 |
5.98 ± 0.44 |
5.69 ± 0.28 |
9.84 ± 0.32 |
0.92 ± 0.21 |
1.87 ± 0.32 |
2.03 ± 0.24 |
4.68 ± 0.13 |
| Week 6 |
4.26 ± 1.5 |
6.15 ± 0.27 |
5.87 ± 0.34 |
9.99 ± 0.23 |
0.74 ± 0.15 |
1.85 ± 0.23 |
1.93 ± 0.11 |
4.79 ± 0.33 |
| Week 8 |
4.76 ± 0.17 |
6.23 ± 0.57 |
5.99 ± 0.32 |
9.62 ± 0.12 |
0.9 ± 0.32 |
1.91 ± 0.14 |
2.16 ± 0.23 |
4.83 ± 0.14 |
| Week 10 |
4.42 ± 0.31 |
6.32 ± 0.36 |
5.97 ± 0.14 |
9.54 ± 0.16 |
0.97 ± 0.35 |
1.94 ± 0.18 |
2.18 ± 0.21 |
4.94 ± 0.44 |
| Week 12 |
4.34 ± 0.29 |
6.35 ± 0.17 |
6.07 ± 0.3 |
10.59 ± 0.4 |
0.98 ± 0.16 |
1.96 ± 0.05 |
2.22 ± 0.12 |
5.11 ± 0.18 |
| Week 14 |
4.53 ± 0.14 |
6.37 ± 0.37 |
6.15 ± 0.47 |
10.35 ± 0.43 |
0.93 ± 0.27 |
1.99 ± 0.22 |
2.23 ± 0.16 |
5.42 ± 0.15 |
| Week 16 |
4.32 ± 0.64 |
6.39 ± 0.32 |
6. 19 ± 0.2 |
11.14 ± 0.19 |
0.99 ± 0.23 |
2.11 ± 0.13 |
2.24 ± 0.19 |
5.87 ± 0.18 |
The values in each group are represented as Means ± Standard deviation. Significant p values (p< 0.05) were detected between (٭) and (٭٭) since the second week’s
values of the study and thereafter. Group I (control or nondiabetic fed on ordinary lab diet); Group II (non-diabetic fed on fatty diet); Group III (diabetic fed on ordinary lab
diet); Group IV (diabetic fed on fatty diet); Day 0 = The first day after fat feeding following induction of diabetes by the injecting streptozotocin. Normal serum TC was < 5.17
mmol/l and normal TG was < 1.7 mmol/l. |
